267 related articles for article (PubMed ID: 23911682)
61. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
[TBL] [Abstract][Full Text] [Related]
62. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
63. How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.
Sountoulides P; Mutomba WF; Bouras E; Lim J; Bourdoumis A; Jain A
Urologia; 2020 Aug; 87(3):142-148. PubMed ID: 31959070
[TBL] [Abstract][Full Text] [Related]
64. [Impact of operator experience on TURB of high-grade non-muscle-invasive bladder cancer--analysis of 254 second resections at a university teaching hospital].
Lazica DA; Degener S; Böttcher S; Brandt AS; Störkel S; Roth S
Aktuelle Urol; 2013 May; 44(3):196-200. PubMed ID: 23712276
[TBL] [Abstract][Full Text] [Related]
65. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
[TBL] [Abstract][Full Text] [Related]
66. Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
Kim W; Song C; Park S; Kim J; Park J; Kim SC; Cho YM; Hong B; Ahn H
J Endourol; 2012 Aug; 26(8):1059-64. PubMed ID: 22390720
[TBL] [Abstract][Full Text] [Related]
67. Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
Akand M; Muilwijk T; Raskin Y; De Vrieze M; Joniau S; Van Der Aa F
Clin Genitourin Cancer; 2019 Aug; 17(4):e784-e792. PubMed ID: 31097388
[TBL] [Abstract][Full Text] [Related]
68. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
69. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
70. Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer 10 years of experience of a referral center.
Žemličková B; Brisuda A
Rozhl Chir; 2022; 101(3):119-128. PubMed ID: 35387468
[TBL] [Abstract][Full Text] [Related]
71. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
[TBL] [Abstract][Full Text] [Related]
72. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
73. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study.
Kobayashi S; Fujii Y; Koga F; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Masuda H; Kihara K
Urol Oncol; 2014 Jan; 32(1):38.e29-36. PubMed ID: 23702087
[TBL] [Abstract][Full Text] [Related]
74. Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
Segal R; Yafi FA; Brimo F; Tanguay S; Aprikian A; Kassouf W
BJU Int; 2012 Apr; 109(7):1026-30. PubMed ID: 21883838
[TBL] [Abstract][Full Text] [Related]
75. Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.
Jaidane M; Bouicha T; Slama A; Hmida W; Hidoussi A; Ben Sorba N; Mosbah F
Urology; 2010 Jun; 75(6):1392-5. PubMed ID: 19781747
[TBL] [Abstract][Full Text] [Related]
76. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
[TBL] [Abstract][Full Text] [Related]
77. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
78. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
Davila HH; Weber T; Burday D; Thurman S; Carrion R; Salup R; Lockhart JL
BJU Int; 2007 Nov; 100(5):1026-9. PubMed ID: 17868423
[TBL] [Abstract][Full Text] [Related]
79. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
Mitra AP; Skinner EC; Miranda G; Daneshmand S
BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
[TBL] [Abstract][Full Text] [Related]
80. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]